| 摘要 |
The present invention relates to the use of 9-cis retinoic acid and derivatives or precursors thereof for the manufacture of a medicament for the treatment of T-helper cell type 1 mediated immune disease as well as to the use of said active substances for the treatment of such diseases, which diseases are eczematoid conditions in a human patient.
|
